Intervention
Ablation
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 15 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
15 shown177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate CancerNCT07145177 · 2026-03-16
RECRUITINGBronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates - UKNCT06869122 · 2025-07-14
RECRUITINGBronchoscopic Microwave Ablation of Lung Tissue in Surgical CandidatesNCT06689488 · 2025-06-17
RECRUITINGAblation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular CarcinomaNCT06644430 · 2024-10-04
RECRUITINGOne-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and AblationNCT07521618 · 2026-04-01
NOT_YET_RECRUITINGLongitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)NCT06798961 · 2024-11-01
ACTIVE_NOT_RECRUITINGVentricular Tachycardia Ablation in LVAD PatientsNCT06063811 · 2023-09-25
UNKNOWNBronchoscopic Microwave Ablation of Lung TissueNCT05786625 · 2023-05-04
ACTIVE_NOT_RECRUITINGAblation in Patients With HF and Symptomatic AF: PULVERISE-AF-CRTNCT05760833 · 2022-12-01
WITHDRAWNEvaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing FunctionNCT07272356 · 2022-11-22
ACTIVE_NOT_RECRUITINGEndovascular GSN Ablation in Subjects With HFpEFNCT04287946 · 2020-02-01
UNKNOWNA Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.NCT03695835 · 2018-04-11
COMPLETEDThe EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)NCT02323854 · 2015-01-01
COMPLETEDComparison of Reverse Remodeling and PVI Versus CFAE and/or Linear Lesions and PVI for Persistent AFNCT01877473 · 2013-05-01
WITHDRAWNPAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)NCT00839566 · 2008-11-01
TERMINATEDCommon conditions
Lung Cancer5Atrial Fibrillation2Heart Failure2Ablation1Adenocarcinoma1Advanced Hepatocellular Carcinoma1Cardiac Death1Cardiac Death, Sudden1Confocal Laser Endomicroscopy1Cryoablation1End-stage Heart Failure1Heart Failure With Preserved Ejection Fraction1Lung Cancer (Non-Small Cell)1Lung Cancer (Suspected or Confirmed)1Lung Metastases From Any Primary1LVAD (Left Ventricular Assist Device)1Metastatic Prostate Cancer1Oligometastasis1Persistent Atrial Fibrillation1Prostate Cancer1Robotic Bronchoscopy System1Systemic Therapy1Ventricular Arrythmia1Ventricular Tachycardia1Wolf Parkinson White Syndrome1
Leading sponsors
Creo Medical Limited
3
Aurimas Macionis
1
Axon Therapies, Inc.
1
Gary Onik MD
1
Guangzhou Medical University
1
Medtronic - MITG
1
Medtronic Cardiac Rhythm and Heart Failure
1
Sun Yat-sen University
1
United States Naval Medical Center, San Diego
1
Universitätsklinikum Köln
1
University Medical Center Groningen
1
University of California, San Francisco
1
Valley Health System
1
Trial status mix
RECRUITING4
ACTIVE_NOT_RECRUITING3
COMPLETED2
UNKNOWN2
WITHDRAWN2
NOT_YET_RECRUITING1
TERMINATED1
Phase mix
NA5
PHASE42
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.